Clinical Trials
13
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)β’ Click on a phase to view related trials
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- First Posted Date
- 2025-08-26
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 233
- Registration Number
- NCT07141706
- Locations
- πΊπΈ
USA01, Fairfax, Virginia, United States
πΊπΈUSA03-0, San Antonio, Texas, United States
π¦πΊAUS01-0, Randwick, New South Wales, Australia
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Conditions
- Solid Tumors
- Interventions
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-09-04
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 492
- Registration Number
- NCT06953089
- Locations
- πΊπΈ
USA06-0, Los Angeles, California, United States
πΊπΈUSA01-0, Wheat Ridge, Colorado, United States
πΊπΈUSA08-0, Florida City, Florida, United States
A Phase 1 Study of DB-2304 in Healthy Adults and SLE Participants
- Conditions
- Systemic Lupus Erythematosus (SLE)
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT06625671
- Locations
- π¦πΊ
Site AUS01-0, Melbourne, Victoria, Australia
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2025-09-18
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT06554795
- Locations
- πΊπΈ
Site USA08-0, Newport Beach, California, United States
πΊπΈSite USA06-0, Washington D.C., District of Columbia, United States
πΊπΈSite USA02, Florida City, Florida, United States
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
- Conditions
- HER2-positive Breast Cancer
- Interventions
- Drug: DB-1303/BNT323
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 228
- Registration Number
- NCT06265428
- Locations
- π¨π³
015, Bengbu, Anhui, China
π¨π³016, Hefei, Anhui, China
π¨π³029, Hefei, Anhui, China
- Prev
- 1
- 2
- 3
- Next